A study to test a medicine (fitusiran) for preventing bleeds in people with severe hemophilia who previously received preventive treatment with emicizumab

Trial Identifier:	SFY17741
Sponsor:	Sanofi
Start Date:	March 2024
Primary Completion Date:	September 2026
Study Completion Date:	May 2028
Condition:	Hemophilia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
TAIWAN, PROVINCE OF CHINA	Taipei, TAIWAN, PROVINCE OF CHINA, 10041

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.